The American Society of Clinical Oncology (ASCO) holds a yearly conference in June to allow researchers and doctors in the cancer community an opportunity to share their research on the newest developments in treatments, technologies, and more for cancers like multiple myeloma.
This year, the conference will be held from May 31st to June 4th, 2024 at McCormick Place in Chicago, Illinois. HealthTree looks forward to meeting with myeloma specialists to cover the latest and greatest insights about myeloma and its care options. Following the event, expect to see HealthTree News articles and HealthTree University videos sharing what we learned at ASCO from myeloma specialists.
We have found that patients who educate themselves about the facets of their disease can be better advocates for themselves and receive improved care and quality of life. Stay tuned for upcoming ASCO content to learn about the latest in myeloma research.
The conference features a variety of sessions, including:
While the ASCO conference is mainly for medical professionals, researchers, and allied health providers, patients can attend if they register. However, it's important to note that the technical nature of the presentations might be challenging for non-medical professionals to understand fully.
HealthTree will write about topics discussed at the conference and share them with the HealthTree community in the form of HealthTree News articles and HealthTree University videos. This will help make information easy for patients to understand.
Subscribe to our newsletter and stay tuned for upcoming ASCO content!
We invite you to click the button below to subscribe to the HealthTree for Myeloma newsletter and stay updated on the latest advancements in multiple myeloma.
JOIN THE HEALTHTREE FOR Myeloma NEWSLETTER
The American Society of Clinical Oncology (ASCO) holds a yearly conference in June to allow researchers and doctors in the cancer community an opportunity to share their research on the newest developments in treatments, technologies, and more for cancers like multiple myeloma.
This year, the conference will be held from May 31st to June 4th, 2024 at McCormick Place in Chicago, Illinois. HealthTree looks forward to meeting with myeloma specialists to cover the latest and greatest insights about myeloma and its care options. Following the event, expect to see HealthTree News articles and HealthTree University videos sharing what we learned at ASCO from myeloma specialists.
We have found that patients who educate themselves about the facets of their disease can be better advocates for themselves and receive improved care and quality of life. Stay tuned for upcoming ASCO content to learn about the latest in myeloma research.
The conference features a variety of sessions, including:
While the ASCO conference is mainly for medical professionals, researchers, and allied health providers, patients can attend if they register. However, it's important to note that the technical nature of the presentations might be challenging for non-medical professionals to understand fully.
HealthTree will write about topics discussed at the conference and share them with the HealthTree community in the form of HealthTree News articles and HealthTree University videos. This will help make information easy for patients to understand.
Subscribe to our newsletter and stay tuned for upcoming ASCO content!
We invite you to click the button below to subscribe to the HealthTree for Myeloma newsletter and stay updated on the latest advancements in multiple myeloma.
about the author
Megan Heaps
Megan joined HealthTree in 2022. As a writer and the daughter of a blood cancer patient, she is dedicated to helping patients and their caregivers understand the various aspects of their disease. This understanding enables them to better advocate for themselves and improve their treatment outcomes. In her spare time, she enjoys spending time with her family, sewing, and cooking.
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.